Annotation Detail for ADAM28
Basic Information
Top
| Gene Symbol: | ADAM28 ( ADAM 28,ADAM23,MDC-L,MDC-Lm,MDC-Ls,MDCL,eMDC II,eMDCII ) |
|---|
| Gene Full Name: | ADAM metallopeptidase domain 28 |
|---|
| Band: | 8p21.2 |
|---|
| Quick Links | Entrez ID:10863; OMIM: 606188; Uniprot ID:ADA28_HUMAN; ENSEMBL ID: ENSG00000042980; HGNC ID: 206 |
|---|
| Relate to Another Database: |
SFARIGene;
denovo-db |
| Desease ID | Desease Name |
|---|
| 1944 | Breast cancer |
| 2066 | Lung cancer |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D002117 |
Calcitriol |
Calcitriol results in decreased expression of ADAM28 mRNA | decreases expression | 16002434
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.55 | 11237771 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
2.73 | 11237771 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
4.72 | 15138306 |
| MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
5.87 | 15572423 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
3.46 | 16289102 18247401 12479363 15754350 16644109 |
| Drugbank ID |
Action |
Drug Name |
Description |
|---|
| DB02046 |
- |
N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid |
|
| DB02215 |
- |
Furoyl-Leucine |
|
| DB02255 |
- |
GM6001 |
|
| DB02996 |
- |
2-(Thiomethylene)-4-Methylpentanoic Acid |
|
| DB03088 |
- |
Pyroglutamic Acid |
|
| DB03880 |
- |
Batimastat |
Antineoplastic Agents;Protease Inhibitors |
| DB08733 |
- |
(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE |
|
Related Pathway Information